Restrictive pattern in spirometry as a predictor of poor survival in chronic heart failure patients on betaceptor-antagonist, with possible indications for heart transplantation

Annals of Transplantation

Volumn 16, Issue 4, 2011, Pages 16-24

  Lizak, Maria K ^a   Zakliczyński, MichaŁ ^a   Jarosz, Anna ^a   Zembala, Marian ^a   Kalarus, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Heart failure; Mortality; Prognosis; Restriction; Spirometry

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HEART FAILURE; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; LOWER LIMIT OF NORMAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORMAL DISTRIBUTION; OXYGEN CONSUMPTION; PROGNOSIS; SPIROMETRY; SURVIVAL;

EID: 84855472926     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.882214     Document Type: Article

References (30)

1. Naum CC, Sciurba FC, Rogers RM: Pulmonary function abnormalities in chronic severe cardiomyopathy preceding cardiac transplantation. Am Rev Respir Dis, 1992; 145: 1334
2. Wright RS, Levine MS, Bellamy PE et al: Ventilatory and diffusion abnormalities in potential heart transplant recipients. Chest, 1990; 98: 816
3. Evans SA, Watson L, Cowley AJ et al: Static lung compliance in chronic heart failure: relation with dyspnoea and exercise capacity. Thorax, 1995; 50: 245
4. Petermann W, Barth J, Entzian P: Heart failure and airway obstruction. Int J Cardiol, 1987; 17: 207
5. Guazzi M: Alveolar-capillary membrane dysfunction in heart failure. Chest, 2003; 124: 1090
6. Olson TP, Kenneth CB, Johnson BD: Pulmonary Function Changes Associated with Cardiomegaly in Chronic Heart Failure. J Card Fail, 2007; 13: 100
7. Agostoni P, Cattadori G, Guazzi M et al: Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure. Am Heart J, 2000; 140: 24
8. Hosenpud JD, Stibolt TA, Atwal K, Shelley D: Abnormal pulmonary function specifically related to congestive heart failure: comparison of patients before and after cardiac transplantation. Am J Med, 1990; 88: 493
9. Curkendall SM, DeLuise C, Jones JK et al: Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol, 2006; 16: 63
10. Huiart L, Ernst P, Suissa S: Cardiovascular morbidity and mortality in COPD. Chest, 2005; 128: 2640
11. Schembri S, Anderson W, Morant S et al: A predictive model of hospitalisation and death from chronic obstructive pulmonary disease. Respir Med, 2009; 103: 1461
12. Rutten FH, Cramer MJ, Lammers JW et al: Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur J Heart Fail, 2006; 8: 706
13. Kjaergaard J, Akkan D, Iversen KK et al: Prognostic importance of pulmonary hypertension in patients with heart failure. Am J Cardiol, 2007; 99: 1146
14. Mascarenhas J, Lourenco P, Lopes R et al: Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications. Am Heart J, 2008; 155: 521
15. Johnston AK, Mannino DM, Hagan GW et al: Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax, 2008; 63: 599
16. Hardie JA, Buist AS, Vollmer WM et al: Risk of overdiagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J, 2002; 20: 1117
17. Celli BR, Halbert RJ, Isonaka S, Schau B: Population impact of different definitions of airway obstruction. Eur Respir J, 2003; 22: 268
18. Global Strategy for Diagnosis, Management, and Prevention of COPD, actualization 2008. http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=2003
19. Mehra MR, Kobashigawa J, Starling R et al: Listing Criteria for Heart Transplantation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates - 2006. J Heart Lung Transplant, 2006; 25: 1024
20. Arena R, Myers J, Williams MA et al: Assessment of Functional Capacity in Clinical and Research Settings: A Scientific Statement From the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. Circulation, 2007; 116: 329
21. Corra U, Mezzani A, Bosimini E, Giannuzzi P: Cardiopulmonary exercise testing and prognosis in chronic heart failure: a prognosticating algorithm for the individual patient. Chest, 2004; 126: 942
22. Komisja Akredytacyjna powołana przez Zarza{ogonek}d Polskiego Towarzystwa Chorob Płuc. Zalecenia Polskiego Towarzystwa Chorob Płuc dotycza{ogonek}ce wykonywania badań spirometrycznych. Pneumonol Alergol Pol, 2006; 74: 6 (in Polish)
23. Damarla M, Celli BR, Mullerova HX, Pinto-Plata VM: Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir Care, 2006; 51: 1120
24. Ries AL, Gregoratos G, Friedman PJ, Clausen JL: Pulmonary function tests in the detection of left heart failure: correlation with pulmonary artery wedge pressure. Respiration, 1986; 49: 241
25. Lizak MK, Zakliczyński M, Jarosz A, Zembala M: The influence of chronic heart failure on pulmonary function tests in patients undergoing orthotopic heart transplantation. Transplant Proc, 2009; 41: 3194
26. Kindman LA, Vagelos RH, Willson K et al: Abnormalities of pulmonary function in patients with congestive heart failure, and reversal with ipratropium bromide. Am J Cardiol, 1994; 73: 258
27. Sin DD, Lacy P, York E, Man SF: Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2004; 170: 760
28. Patel IS, Roberts NJ, Lloyd-Owen SJ et al: Airway epithelial inflammatory responses and clinical parameters in COPD. Eur Respir J, 2003; 22: 94
29. Man SF, Xuekui Z, Vessey R et al: The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study. Ther Adv Respir Dis, 2009; 3: 73
30. Sin DD, Wu L, Anderson JA et al: Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax, 2005; 60: 992